who should not take glp-1 receptor agonists glp 1 drugs The and Obesity: How Diabetes Drugs MYTH BUSTER #1 “Weight-loss injections
Description
Rights and permissions About this article Cite this article Goldney, J., Davies, M.J
Researchers reported 75 ADRD cases among GLP-1 users over a mean follow-up of 2.22 years, compared with 639 ADRD cases among other GLD users over mean follow-up of 3.74 years
R.BlondeL.PratleyR
See permissions for copyright questions and/or permission requests.
Sadeghi A, Mousavi SM, Mokhtari T, Parohan M, Milajerdi A
